The candida precipitin test in an immunosuppressed population

Area of Science:

• Medical Mycology
• Infectious Diseases
• Immunology

Background:

• Invasive candidiasis is a serious fungal infection, particularly in immunosuppressed patients.
• Accurate and timely diagnosis is crucial for effective treatment and improved patient outcomes.
• Current diagnostic methods for invasive candidiasis have limitations.

Purpose of the Study:

• To evaluate the diagnostic utility of candida precipitin (CP) antibody detection.
• To assess the sensitivity and specificity of the counterimmunoelectrophoresis (CIE) method for diagnosing invasive candidiasis.

Main Methods:

• Ninety-one high-risk, immunosuppressed patients with suspected invasive candidiasis were enrolled.
• The counterimmunoelectrophoresis (CIE) method was used to detect candida precipitin (CP) antibody during septic episodes.
• Diagnostic confirmation of invasive candidiasis was based on clinical and microbiological data.

Main Results:

• Candida precipitins were detected in 50% of patients with confirmed invasive candidiasis.
• The test showed a specificity of 69%, with precipitins found in 31% of patients without serious fungal infection.
• In patients with questionable diagnoses who died, 57% tested positive for CP antibody.

Conclusions:

• The candida precipitin (CP) antibody test, using CIE, demonstrates poor diagnostic performance for invasive candidiasis in this high-risk population.
• The low sensitivity (50%) and specificity (69%) indicate that CP antibody detection is neither a reliable marker for confirming nor excluding invasive candidiasis.
• Further research into more sensitive and specific diagnostic markers for invasive candidiasis is warranted.